Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

phospholipase C, beta 1 (phosphoinositide-Specific) (PLCB1) Peptide

PLCB1 Reactivité: Humain Hôte: Synthetic BP, WB
N° du produit ABIN5510838
  • Antigène Tous les produits Phospholipase C beta 1 (PLCB1)
    Phospholipase C beta 1 (PLCB1) (phospholipase C, beta 1 (phosphoinositide-Specific) (PLCB1))
    Origine
    Humain
    Source
    • 3
    Synthetic
    Application
    Blocking Peptide (BP), Western Blotting (WB)
    Attributs du produit
    This is a synthetic peptide designed for use in combination with anti-PLCB antibody (Catalog #: ARP74371_P050) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
  • Indications d'application
    Optimal working dilution should be determined by the investigator.
    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Reconstitution
    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
    Stock
    -20 °C
    Stockage commentaire
    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Antigène
    Phospholipase C beta 1 (PLCB1) (phospholipase C, beta 1 (phosphoinositide-Specific) (PLCB1))
    Synonymes
    PLCB1 Peptide, 3110043I21Rik Peptide, AI132408 Peptide, Plcb Peptide, mKIAA0581 Peptide, EIEE12 Peptide, PI-PLC Peptide, PLC-154 Peptide, PLC-I Peptide, PLC154 Peptide, PLCB1A Peptide, PLCB1B Peptide, PLC'1 Peptide, PLCbeta1 Peptide, Phosphb Peptide, RATPHOSPHB Peptide, phospholipase C beta 1 Peptide, phospholipase C beta 1 S homeolog Peptide, phospholipase C, beta 1 Peptide, PLCB1 Peptide, plcb1.S Peptide, Plcb1 Peptide
    Sujet
    This gene encodes a member of the 1-acylglycerol-3-phosphate O-acyltransferase family. The protein is located within the endoplasmic reticulum membrane and converts lysophosphatidic acid to phosphatidic acid, the second step in de novo phospholipid biosynthesis. Mutations in this gene have been associated with congenital generalized lipodystrophy (CGL), or Berardinelli-Seip syndrome, a disease characterized by a near absence of adipose tissue and severe insulin resistance. Alternate transcriptional splice variants, encoding different isoforms, have been characterized.

    Protein Size: 278
    Poids moléculaire
    30 kDa
    ID gène
    10555
    NCBI Accession
    NP_006403
    UniProt
    O15120
Vous êtes ici:
Support technique